Executive Leadership Team
Rob Schott, M.D., M.P.H, F.A.C.C.
Senior Vice President, Head of Development
Rob Schott, M.D., M.P.H., F.A.C.C., serves as Sangamo’s Senior Vice President and Head of Development. He is responsible for leading Sangamo’s clinical development organization across all phases of drug development and regulatory approval. Prior to joining Sangamo in 2021, Dr. Schott served as the Chief Medical Officer at Chorus, an autonomous early-phase development engine inside of Eli Lilly, where he oversaw teams working to expand Eli Lilly’s pipeline. He previously joined Eli Lilly in 2014 as a Global Launch Leader. Earlier in his career, Dr. Schott served as a Cardiovascular Department Chair and Vice President of Medical Affairs at Sutter Medical Center Sacramento while continuing to care for patients as an invasive cardiologist.
Dr. Schott received his undergraduate and medical degrees from the University of Michigan. He trained in cardiovascular medicine at the Massachusetts General Hospital after working as a post-doctoral fellow at the Harvard Medical School.